Company / Depreciation & Amortization
Tvardi Therapeutics, Inc. Depreciation & Amortization History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$248.0K
FY2024
5-year range
$198.0K / $370.0K
FY2020-FY2024
Trend
+0.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 10 years, ranging from $198,000 in FY2021 to $1M in FY2018.
Based on SEC 10-K filings.
$248,000 in FY2024 with a 5-year CAGR of -12.9%.
Increased from $209,000 to $248,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +7.8%
- 5-Year CAGR
- -12.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -12.9%, indicating a declining trend.
- In FY2024, depreciation & amortization increased 0.0% year-over-year.
- Peak depreciation & amortization was recorded in FY2018.
- Lowest depreciation & amortization in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $248.0K | +0.0% |
| FY2023 | $248.0K | +18.7% |
| FY2022 | $209.0K | +5.6% |
| FY2021 | $198.0K | -46.5% |
| FY2020 | $370.0K | -25.3% |
| FY2019 | $495.0K | -66.2% |
| FY2018 | $1.5M | +74.6% |
| FY2017 | $839.0K | +7.2% |
| FY2016 | $783.0K | -0.8% |
| FY2015 | $789.0K | -22.7% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026